Karl McKinstry

Karl McKinstry

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
TST M Strutt
T M Strutt
KDK Dhume
K Dhume
CFC M Finn
C M Finn
JHJ H Hwang
J H Hwang
CCC Castonguay
C Castonguay
KMKarl McKinstry
Karl McKinstry
Tissue-resident memory T cells (TRM) provide optimal defense at the sites of infection, but signals regulating their development are unclear, especially for CD4 T cells. Here we identify two distinct pathways that lead to the generation of CD4 TRM in the lungs following influenza infection. The TRM are transcriptionally distinct from conventional memory CD4 T cells and share a gene signature with CD8 TRM. The CD4 TRM are superior cytokine producers compared with conventional memory cells, can protect otherwise naive mice against a lethal influenza challenge, and display functional specialization by inducing enhanced inflammatory responses from dendritic cells compared with conventional memory cells. Finally, we demonstrate than an interleukin (IL)-2-dependent and a novel IL-2-independent but IL-15-dependent pathway support the generation of cohorts of lung TRM.


20 September 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
TZTianyu Zheng
Tianyu Zheng
CFCaroline Finn
Caroline Finn
CPChristopher J. Parrett
Christopher J. Parrett
KDKunal Dhume
Kunal Dhume
JHJi Hae Hwang
Ji Hae Hwang
Qun HuoQun Huo
Qun Huo

15 October 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Tara M. StruttTara M. Strutt
Tara M. Strutt
KMKarl McKinstry
Karl McKinstry
YKYi Kuang
Yi Kuang
CFCaroline M. Finn
Caroline M. Finn
JHJi Hae Hwang
Ji Hae Hwang
SSSusan L. Swain
Susan L. Swain
Memory T cells can often respond against pathogens that have evaded neutralizing Abs and are thus key to vaccine-induced protection, yet the signals needed to optimize their responses are unclear. In this study, we identify a dramatic and selective requirement for IL-6 to achieve optimal memory CD4 T cell recall following heterosubtypic influenza A virus (IAV) challenge of mice primed previously with wild-type or attenuated IAV strains. Through analysis of endogenous T cell responses and adoptive transfer of IAV-specific memory T cell populations, we find that without IL-6, CD4+, but not CD8+, secondary effector populations expand less and have blunted function and antiviral impact. Early and direct IL-6 signals to memory CD4 T cells are required to program maximal secondary effector responses at the site of infection during heterosubtypic challenge, indicating a novel role for a costimulatory cytokine in recall responses.

1 September 2018 in Cellular Immunology
Verified
Journal Article
Closed access
JTJoanne D. Tejero
Joanne D. Tejero
NANicole C. Armand
Nicole C. Armand
CFCaroline M. Finn
Caroline M. Finn
KDKunal Dhume
Kunal Dhume
TSTara M. Strutt
Tara M. Strutt
KMKarl McKinstry
Karl McKinstry

5 April 2024 in Cells
Verified
Journal Article
Open access
PDF file
CFCaroline Finn
Caroline Finn
KMKarl McKinstry
Karl McKinstry
Current Influenza A virus (IAV) vaccines, which primarily aim to generate neutralizing antibodies against the major surface proteins of specific IAV strains predicted to circulate during the annual ‘flu’ season, are suboptimal and are characterized by relatively low annual vaccine efficacy. One approach to improve protection is for vaccines to also target the priming of virus-specific T cells that can protect against IAV even in the absence of preexisting neutralizing antibodies. CD4 T cells represent a particularly attractive target as they help to promote responses by other innate and adaptive lymphocyte populations and can also directly mediate potent effector functions. Studies in murine models of IAV infection have been instrumental in moving this goal forward. Here, we will review these findings, focusing on distinct subsets of CD4 T cell effectors that have been shown to impact outcomes. This body of work suggests that a major challenge for next-generation vaccines will be to prime a CD4 T cell population with the same spectrum of functional diversity generated by IAV infection. This goal is encapsulated well by the motto ‘ex pluribus unum’: that an optimal CD4 T cell response comprises many individual specialized subsets responding together.